Document is current
Any future updates will be listed below
-
Authors
Jørstad, Øystein Kalsnes https://orcid.org/0000-0003-1259-0653
Lee, Andrew G.
-
Funding
Funding for this research was provided by:
Roche (N/A, N/A)
- License Information
-
More Information
Article History
Received: 27 February 2025
Revised: 3 March 2025
Accepted: 13 March 2025
First Online: 25 March 2025
Competing interests
: ØKJ: Allergan (speaker, consultant), Bayer (speaker, consultant), Chiesi Farmaceutici (speaker), Roche (consultant), and SJJ Solutions (speaker, consultant, and royalties). AGL: Alexion (speaker), Amgen/Horizon (speaker), AstraZeneca (consultant), Bristol Mayers Squibb (consultant), National Football League (consultant), Catalyst (consultant), Viridian (consultant), Ethyreal (consultant), NASA (consultant), US Department of Justice (consultant), Dompe (consultant), and Stoke (consultant). AGL is a member of the Eye editorial board.
